PS Ratio: 35.98

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/S ratio high or low?

The P/S ratio of 35.98 is 247% above its estimated 2-year average of 10.36, near the low end of its estimated 2-year range (1.71–364.74).

As of 2026-10-06T14:12:29.377Z. 69.34% below its estimated 12-month average of 117.36.

IRD PS Ratio Metrics

P/S vs. estimated history

At 35.98, P/S is above its estimated 2-year median — higher than 72% of readings in its estimated 2-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Sales Valuation

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio FAQ

What is the P/S ratio for Opus Genetics, Inc. (IRD)?

The P/S ratio for IRD stock is 35.98.

Is Opus Genetics, Inc.'s P/S ratio high or low?

The P/S ratio of 35.98 is 247% above its estimated 2-year average of 10.36, near the low end of its estimated 2-year range (1.71–364.74).

What is the estimated TTM average P/S ratio for Opus Genetics, Inc. (IRD)?

The estimated TTM average P/S ratio for IRD stock is 117.36.

Showing the most recent 260 of 508 data points. The chart above shows the full history.

Related Metrics